Literature DB >> 8813867

Psychological response to growth hormone treatment in short normal children.

A B Downie1, J Mulligan, E S McCaughey, R J Stratford, P R Betts, L D Voss.   

Abstract

This study provides a controlled assessment of the psychological (and physical) effects of growth hormone treatment. Fifteen short 'normal' children (height SD score < -2) have been treated with growth hormone since the age of 7/8 years. They, together with untreated short controls and average controls (10th-90th centiles), were assessed at recruitment, after three years, and after five years. Only the treated group showed a significant height increase (SD score -2.44 to -1.21 over five years). No significant differences were found at recruitment, three years, or five years in IQ, attainment, behaviour, or self esteem. Also at five years, there were no significant differences in locus of control, self perception, or parental perceptions of competence. Both short groups displayed less satisfaction with their height than the controls (p < 0.01), though all groups were optimistic of being tall adults. The treated children were no more unrealistic over final height than the untreated children. To date, no psychological benefits of treatment have been demonstrated; but nor have there been any discernible ill effects for either the treated or the untreated children.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8813867      PMCID: PMC1511660          DOI: 10.1136/adc.75.1.32

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  13 in total

Review 1.  Is taller really better? Growth hormone therapy in short children.

Authors:  D S Diekema
Journal:  Perspect Biol Med       Date:  1990       Impact factor: 1.416

Review 2.  The social cost of being short: societal perceptions and biases.

Authors:  L E Underwood
Journal:  Acta Paediatr Scand Suppl       Date:  1991

3.  Growth hormone deficiency, brain development, and intelligence.

Authors:  H F Meyer-Bahlburg; J A Feinman; M H MacGillivray; T Aceto
Journal:  Am J Dis Child       Date:  1978-06

4.  Studies in the psychology of dwarfism. II. Personality maturation and response to growth hormone treatment in hypopituitary dwarfs.

Authors:  J Money; E Pollitt
Journal:  J Pediatr       Date:  1966-03       Impact factor: 4.406

5.  Psychological aspects in children and adolescents with hypopituitarism.

Authors:  H Frisch; G Häusler; S Lindenbauer; S Singer
Journal:  Acta Paediatr Scand       Date:  1990 Jun-Jul

Review 6.  Growth hormone deficiency in children has psychological and educational co-morbidity.

Authors:  B Stabler; P T Siegel; R R Clopper
Journal:  Clin Pediatr (Phila)       Date:  1991-03       Impact factor: 1.168

7.  Perceptions of self and short stature: effects of two years of growth hormone treatment.

Authors:  T J Boulton; S M Dunn; C A Quigley; J J Taylor; L Thompson
Journal:  Acta Paediatr Scand Suppl       Date:  1991

8.  Short stature: a psychosocial burden requiring growth hormone therapy?

Authors:  D E Sandberg; A E Brook; S P Campos
Journal:  Pediatrics       Date:  1994-12       Impact factor: 7.124

9.  Growth hormone treatment in hypopituitary dwarfs: longitudinal psychological effects.

Authors:  M Kusalic; C Fortin
Journal:  Can Psychiatr Assoc J       Date:  1975-08

10.  Who needs growth hormone?

Authors:  H F Stirling; C J Kelnar
Journal:  J R Soc Med       Date:  1994-09       Impact factor: 18.000

View more
  8 in total

Review 1.  Should short children who are not deficient in growth hormone be treated?

Authors:  D E Sandberg
Journal:  West J Med       Date:  2000-03

Review 2.  Growing up with idiopathic short stature: psychosocial development and hormone treatment; a critical review.

Authors:  H Visser-van Balen; G Sinnema; R Geenen
Journal:  Arch Dis Child       Date:  2006-05       Impact factor: 3.791

3.  Personality functioning: the influence of stature.

Authors:  F Ulph; P Betts; J Mulligan; R J Stratford
Journal:  Arch Dis Child       Date:  2004-01       Impact factor: 3.791

4.  In children with idiopathic short stature, what advantage does administering recombinant growth hormone have over observation in final adult height?: Part A: Evidence-based answer and summary.

Authors:  Titus Chan; Terry P Klassen
Journal:  Paediatr Child Health       Date:  2003-11       Impact factor: 2.253

5.  Behavioral evaluation of GH treatment in short statured children and adolescents: findings from a pilot study.

Authors:  H C Steinhausen; H G Dörr; Z Malin
Journal:  J Endocrinol Invest       Date:  2002-04       Impact factor: 4.256

Review 6.  Growth hormone treatment in non-growth hormone-deficient short children.

Authors:  S Loche; M R Casini; G M Ubertini; M Cappa
Journal:  J Endocrinol Invest       Date:  2005-02       Impact factor: 4.256

7.  Idiopathic short stature: decision making in growth hormone use.

Authors:  Nidhi Maheshwari; Naveen K Uli; Sumana Narasimhan; Leona Cuttler
Journal:  Indian J Pediatr       Date:  2011-11-19       Impact factor: 1.967

Review 8.  Growth hormone therapy and quality of life in adults and children.

Authors:  Deborah J Radcliffe; Joseph S Pliskin; J B Silvers; Leona Cuttler
Journal:  Pharmacoeconomics       Date:  2004       Impact factor: 4.981

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.